Skip to product information
1 of 1

Omni Peptides

MOTS-c

Regular price Dhs. 300.00 AED
Regular price Sale price Dhs. 300.00 AED
Sale Sold out
CHOOSE YOUR FORMAT

Size
Quantity
Lyophilised & sealed vials
Independent COA · ≥99% purity
Cold-chain dispatch · same day Dubai
Discreet · unbranded outer packaging

Clean GH boost, recovery, fat metabolism

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a synthetic version of the naturally occurring 16-amino-acid mitochondrial-derived peptide (MDP) encoded by a short open reading frame within the mitochondrial 12S rRNA gene (MT-RNR1). This research compound has attracted significant scientific interest for its role as a metabolic regulator and exercise mimetic. Preliminary and advanced preclinical studies indicate that MOTS-c may activate AMP-activated protein kinase (AMPK), enhance glucose uptake in skeletal muscle, promote metabolic flexibility, reduce insulin resistance, and support mitochondrial biogenesis. Researchers utilize this peptide in laboratory and animal models to explore mechanisms of energy homeostasis, particularly in models of obesity, type 2 diabetes, aging, and exercise physiology. As a research-grade compound, MOTS-c is intended exclusively for in vitro and animal studies. Scientists value its unique mitochondrial origin, systemic hormonal-like actions, and potential to elucidate mitochondrial-nuclear communication in metabolic health.

Molecular Formula
C₁₀₁H₁₅₂N₂₈O₂₂S₂
Molecular Weight
2174.6 g/mol
Sequence
Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
01 Metabolic Homeostasis and Insulin Sensitivity
Preclinical investigations show that MOTS-c improves insulin sensitivity, enhances glucose uptake in skeletal muscle via the folate-AICAR-AMPK pathway, and counters high-fat diet-induced insulin resistance and obesity in various models.
02 Exercise Mimetic Effects
MOTS-c is upregulated in response to exercise and mimics many of its benefits, including increased energy expenditure, improved physical performance, and metabolic adaptations in skeletal muscle, with enhanced endurance observed in aged and obese animal models.
03 Obesity and Weight Management
Studies demonstrate that MOTS-c reduces body weight gain, promotes fat oxidation, and prevents diet-induced obesity through modulation of lipid metabolism and thermogenesis in adipose tissue.
04 Aging and Longevity Support
Research highlights its role in counteracting age-related metabolic decline, improving muscle function, and potentially extending healthspan by enhancing mitochondrial stress responses and reducing oxidative damage.
05 Broader Protective Effects
Investigations suggest benefits in bone metabolism regulation (promoting osteoblast activity and inhibiting osteoclastogenesis), liver health (reducing steatosis in NAFLD models), anti-inflammatory actions, and protection against metabolic stress in various organ systems.
Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.

Molecular Formula
C₁₀₁H₁₅₂N₂₈O₂₂S₂
Molecular Weight
2174.6 g/mol
Sequence
Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg

— About this compound

MOTS-c is a mitochondrial-derived peptide.

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a synthetic version of the naturally occurring 16-amino-acid mitochondrial-derived peptide (MDP) encoded by a short open reading frame within the mitochondrial 12S rRNA gene (MT-RNR1). This research compound has attracted significant scientific interest for its role as a metabolic regulator and exercise mimetic. Preliminary and advanced preclinical studies indicate that MOTS-c may activate AMP-activated protein kinase (AMPK), enhance glucose uptake in skeletal muscle, promote metabolic flexibility, reduce insulin resistance, and support mitochondrial biogenesis. Researchers utilize this peptide in laboratory and animal models to explore mechanisms of energy homeostasis, particularly in models of obesity, type 2 diabetes, aging, and exercise physiology. As a research-grade compound, MOTS-c is intended exclusively for in vitro and animal studies. Scientists value its unique mitochondrial origin, systemic hormonal-like actions, and potential to elucidate mitochondrial-nuclear communication in metabolic health.

VIAL ANATOMY
LYOPHILISED VIAL
Flip-off cap
Tamper-evident seal
Rubber stopper
Bacteriostatic-water compatible
Batch-labelled body
Lot & expiry printed
USP Type I glass
Borosilicate, sealed
MOTS-c vial
MOTS-c
10mg
DUBAI PEPTIDES
RESEARCH USE ONLY
BLACK RESEARCH SERIES

Research Applications

Where researchers apply it.

01 Metabolic Homeostasis and Insulin Sensitivity
Preclinical investigations show that MOTS-c improves insulin sensitivity, enhances glucose uptake in skeletal muscle via the folate-AICAR-AMPK pathway, and counters high-fat diet-induced insulin resistance and obesity in various models.
02 Exercise Mimetic Effects
MOTS-c is upregulated in response to exercise and mimics many of its benefits, including increased energy expenditure, improved physical performance, and metabolic adaptations in skeletal muscle, with enhanced endurance observed in aged and obese animal models.
03 Obesity and Weight Management
Studies demonstrate that MOTS-c reduces body weight gain, promotes fat oxidation, and prevents diet-induced obesity through modulation of lipid metabolism and thermogenesis in adipose tissue.
04 Aging and Longevity Support
Research highlights its role in counteracting age-related metabolic decline, improving muscle function, and potentially extending healthspan by enhancing mitochondrial stress responses and reducing oxidative damage.
05 Broader Protective Effects
Investigations suggest benefits in bone metabolism regulation (promoting osteoblast activity and inhibiting osteoclastogenesis), liver health (reducing steatosis in NAFLD models), anti-inflammatory actions, and protection against metabolic stress in various organ systems.

— Verified & Documented

Every vial is backed by a Certificate of Analysis.

Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.

Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.

>99%
HPLC Purity
MS
Identity Confirmed
Certificate of Analysis
MOTS-C · BATCH MO40-0310 · QC RELEASE
PASS
IdentityConfirmed
Mass48.34 mg
Purity99.04%
AppearanceWhite Lyophilised
LabJanoshik Analytical (Independant)
Date24/03/26

Storage & Handling

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.